E-LIB Suche - Ergebnisse für: Barretina-Ginesta, María Pilar

1

SEOM–GEICO clinical guideline on epithelial ovarian cancer ..:

Perez-Fidalgo, Jose Alejandro ; Gálvez-Montosa, Fernando ; Guerra, Eva María...
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

2

Analysis of Tumor Microenvironment Changes after Neoadjuvan..:

Tavira, Beatriz ; Iscar, Teresa ; Manso, Luis...
Clinical Cancer Research. 30 (2023) 1 - p. 176-186 , 2023

Link: https://doi.org/10.1158/..

3

Esophageal Infiltration by High-Grade Serous Ovarian Carcin..:

Carbó-Bagué, Anna ; Cerón-Nasarre, Laura ; Valls-Masot, Laia...
Case Reports in Oncology. 16 (2023) 1 - p. 1436-1442 , 2023

Link: https://doi.org/10.1159/..

4

The Scarface Score: Deciphering Response to DNA Damage Agen..:

Fernández-Serra, Antonio ; López-Reig, Raquel ; Márquez, Raúl...
Cancers. 15 (2023) 11 - p. 3030 , 2023

Link: https://doi.org/10.3390/..

5

SEOM-GEICO clinical guidelines on endometrial cancer (2021):

Barretina-Ginesta, María Pilar ; Quindós, María ; Alarcón, Jesús Damián...
Clinical and Translational Oncology. 24 (2022) 4 - p. 625-634 , 2022

Link: https://doi.org/10.1007/..

6

Evaluation of Prognostic and Predictive Significance of Cir..:

Halvorsen, Ann Rita ; Kristensen, Gunnar ; Embleton, Andy...
Disease Markers. 2017 (2017) - p. 1-9 , 2017

Link: https://doi.org/10.1155/..

7

First-line PARP inhibitor maintenance treatment in ovarian ..:

Masvidal Hernandez, Maria ; Cros Costa, Sara ; Salvador Coloma, Carmen...
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

8

Side Effects from Cancer Therapies and Perspective of 1044 ..:

Woopen, Hannah ; Keller, Maren ; Zocholl, Dario...
Cancers. 15 (2023) 22 - p. 5428 , 2023

Link: https://doi.org/10.3390/..

9

Prognostic Role of Neutrophil, Monocyte and Platelet to Lym..:

Plaja, Andrea ; Teruel, Iris ; Ochoa-de-Olza, Maria...
International Journal of Molecular Sciences. 24 (2023) 14 - p. 11420 , 2023

Link: https://doi.org/10.3390/..

10

Risk of endometrial cancer after RRSO in BRCA 1/2 carriers:..:

Pla-Juher, Helena ; Pardo, Marta ; Izquierdo, Àngel J....
Clinical and Translational Oncology. 26 (2023) 4 - p. 1033-1037 , 2023

Link: https://doi.org/10.1007/..

11

Olaparib as first line in BRCA-mutated advanced ovarian car..:

Moya-Alarcón, Carlota ; González-Domínguez, Almudena ; Ivanova-Markova, Yoana...
Gynecologic Oncology. 164 (2022) 2 - p. 406-414 , 2022

Link: https://doi.org/10.1016/..

12

Quality-adjusted time without symptoms of disease or toxici..:

Barretina-Ginesta, Maria-Pilar ; Monk, Bradley J. ; Han, Sileny...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211261 , 2022

Link: https://doi.org/10.1177/..

13

Safety and efficacy of the tumor-selective adenovirus enade..:

Moreno, Victor ; Barretina-Ginesta, Maria-Pilar ; García-Donas, Jesús...
Journal for ImmunoTherapy of Cancer. 9 (2021) 12 - p. e003645 , 2021

Link: https://doi.org/10.1136/..

14

Clinical Activity and Safety of the Anti-PD-1 Monoclonal An..:

Oaknin, Ana ; Tinker, Anna V ; Gilbert, Lucy...
Future Oncology. 17 (2021) 29 - p. 3781-3785 , 2021

Link: https://doi.org/10.2217/..

15

Management of advanced ovarian cancer in Spain: an expert D..:

Redondo, Andres ; Oaknin, Ana ; Rubio, Maria Jesus...
Journal of Ovarian Research. 14 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..